Dimensional Fund Advisors LP Charles River Laboratories International, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 862,254 shares of CRL stock, worth $116 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

862,254

Previous 663,504 29.95%

Holding current value

$116 Million

Previous $122 Million 5.96%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$150.52 - $190.14 $29.9 Million - $37.8 Million	198,750 Added 29.95%	862,254 $130 Million
Q4 2024 Feb 13, 2025	BUY	$178.58 - $220.69 $24.3 Million - $30 Million	135,986 Added 25.78%	663,504 $122 Million
Q3 2024 Nov 07, 2024	SELL	$187.96 - $245.29 $6.31 Million - $8.23 Million	-33,557 Reduced 5.98%	527,518 $104 Million
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $19.3 Million - $25.2 Million	93,682 Added 20.04%	561,075 $116 Million
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $2.96 Million - $3.98 Million	-14,553 Reduced 3.02%	467,393 $127 Million
Q4 2023 Feb 07, 2024	BUY	$164.52 - $238.84 $13.3 Million - $19.3 Million	80,698 Added 20.11%	481,946 $114 Million
Q3 2023 Nov 09, 2023	BUY	$194.44 - $217.61 $3.13 Million - $3.51 Million	16,122 Added 4.19%	401,248 $78.6 Million
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $5.82 Million - $6.67 Million	31,705 Added 8.97%	385,126 $81 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $6.29 Million - $8.52 Million	32,796 Added 10.23%	353,421 $71.3 Million
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $6.19 Million - $7.86 Million	31,420 Added 10.86%	320,625 $69.8 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $4.37 Million - $6 Million	23,943 Added 9.03%	289,205 $56.9 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $1.45 Million - $2.15 Million	-7,103 Reduced 2.61%	265,262 $56.8 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $3.54 Million - $5.01 Million	-13,837 Reduced 4.83%	272,365 $77.4 Million
Q4 2021 Feb 09, 2022	SELL	$351.38 - $448.68 $30.1 Million - $38.5 Million	-85,711 Reduced 23.05%	286,202 $108 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $6.87 Million - $8.45 Million	-18,444 Reduced 4.72%	371,913 $153 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $8.85 Million - $11.2 Million	-30,096 Reduced 7.16%	390,357 $144 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $2.87 Million - $3.44 Million	-11,491 Reduced 2.66%	420,453 $122 Million
Q4 2020 Feb 25, 2021	BUY	$222.0 - $252.62 $95.9 Million - $109 Million	431,944 New	431,944 $108 Million

Others Institutions Holding CRL

# of Institutions

649

Shares Held

55M

Call Options Held

695K

Put Options Held

809K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $6.87B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Charles River Laboratories International, Inc. Transaction History